Public Comment

The public comment period for OMMA's proposed permanent rules begins on Monday, Dec. 1, 2025, and closes at 5 p.m. Wednesday, Jan. 7, 2026.

•  Proposed Permanent Rules
  •  Chapter 1 Notice of Rulemaking Intent
  •  Chapter 1 Proposed Permanent Rule Document
  •  Chapter 10 Notice of Rulemaking Intent
  •  Chapter 10 Proposed Permanent Rule Document

A comment form will be added to this page on Dec. 1. You can use the form to comment on the proposed rules until 5 p.m. Jan. 7.

You can also comment in person during the public meeting on Jan. 7 at 9 a.m. in Room 535 of the Oklahoma State Capitol (2300 N Lincoln Blvd.) . The meeting will be livestreamed and recorded on the Oklahoma State Senate website. Anyone who wishes to speak must sign in at the door by 9:05 a.m.

The proposed rules implement newly passed legislation like HB 2807, SB 518, SB 774, SB 1039 and SB 1066 from the 2025 legislative session and clarify sections of current rules. Amendments to allow display samples of up to 3.5 grams and make employee credentials valid for one year after the date they’re issued are meant to simplify regulatory requirements for Oklahoma businesses, while amendments to existing lab testing rules provide beneficial clarification. 

The public comment period is part of OMMA's rulemaking process. More details are available on the rulemaking page. 

View a summary of the changes below: 

• Updates to commercial transporter warehouse requirements for HB 2807 (2025) were added to OAC 442:10-3-1 and OAC 442:10-3-6. 
  
• Changes to the national fingerprint-based background check requirement for HB 2807 (2025) were added to OAC 442:10-5-1.1. 
• Rules requiring medical marijuana to be sold in pre-packaged quantities for HB 2807 (2025) were added to OAC 442:10-7-1 and OAC 442:10-7-2.  
• An additional warning label required by SB 518 (2025) was added to rules at OAC 442:10-7-1(d)(2) and OAC 442:10-5-8(d)(7). 
• Changes to the patient license number and a PDF417 barcode, required by SB 774 (2025), were updated at OAC 442:10-2-6(7). 
• Rules requiring patient applications to be resubmitted within 30 days of rejection required by SB 1039 (2025) were added to OAC 442:10-2-1(g), OAC 442:10-2-2(h), and OAC 442:10-2-4(e). 
• Changes requiring commercial applicants to pay all required license and application fees within 45 days of notification from OMMA, per SB 1039 (2025), were added to OAC 442:10-4-1(b), OAC 442:10-5-1(b), OAC 442:10-5-2(a), OAC 442:10-5-3(a) and OAC 442:10-9-1(c).  
• Updates to the registry of recommending physicians and new medical education and continuing medical education requirements for SB 1066 (2025) were added to OAC 442:10-1-9 and OAC 442:10-1-9.1 
• Proposed amendments to lab rules in OAC 442:10-8-1 and OAC 442:10-8-3 clarify existing rules regarding manufacturer’s instructions for use, when specific enrichment steps or quality control samples are required, inventory tag requirements and fix minor typos and/or rule inconsistencies.  
• OAC 442:10-5-1.1(13)(D) is amended to make employee credentials valid for one year after the date issued, instead of expiring on Jan. 31.  
• Amendments to OAC 442:10-5-14(a) and OAC 442:10-5-16(s)(2) allow display samples of up to 3.5 grams, a size more consistent with industry standards and pre-packaging requirements.